Shingo Kano
Chief Executive Officer presso Aphoenix, Inc.
Profilo
Shingo Kano is the President & Chief Executive Officer at Aphoenix, Inc. He previously worked as an Outside Director at Medical & Biological Laboratories Co. Ltd.
Kano received his undergraduate degree from Tokyo University of Agriculture in 1987, his graduate degree from the University of Tokyo in 1989, and his doctorate from the University of Tokyo in 2002.
Posizioni attive di Shingo Kano
| Società | Posizione | Inizio |
|---|---|---|
Aphoenix, Inc.
 Aphoenix, Inc. Medical/Nursing ServicesHealth Services Aphoenix, Inc. is a holding company that operates as a chemical genomics firm. It specializes in the affinity purification technology using special nano-scale beads and other supporting technologies, such as medicinal chemistry, mass spectroscopy, informatics and molecular, biology. The firm exploits drugs, which lack known mechanisms of action as probes for discovering druggable targets, and then develop such compounds against validated targets. The company was founded in 2002 and is headquartered in Tokyo, Japan . | Chief Executive Officer | - |
Precedenti posizioni note di Shingo Kano
| Società | Posizione | Fine |
|---|---|---|
| MEDICAL & BIOLOGICAL LABORATORIES CO., LTD. | Director/Board Member | - |
Formazione di Shingo Kano
| University of Tokyo | Doctorate Degree |
| Tokyo University of Agriculture | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Medical & Biological Laboratories Co. Ltd.
 Medical & Biological Laboratories Co. Ltd. BiotechnologyHealth Technology Medical & Biological Laboratories Co., Ltd. engages in the research, development, manufacture and sale of biological products. It operates through the Reagents and Investment segments. The Reagent segment supplies, manufactures, and sells clinical reagents and research reagents, and its related equipment and instruments. The Investment segment deals with investments on bio-related enterprises and mediates technical partnership. The company was founded on August 23, 1969 and is headquartered in Nagoya, Japan. | Health Technology |
Aphoenix, Inc.
Aphoenix, Inc. Medical/Nursing ServicesHealth Services Aphoenix, Inc. is a holding company that operates as a chemical genomics firm. It specializes in the affinity purification technology using special nano-scale beads and other supporting technologies, such as medicinal chemistry, mass spectroscopy, informatics and molecular, biology. The firm exploits drugs, which lack known mechanisms of action as probes for discovering druggable targets, and then develop such compounds against validated targets. The company was founded in 2002 and is headquartered in Tokyo, Japan . | Health Services |
- Borsa valori
- Insiders
- Shingo Kano
